Maybe There Was an Egg Cartel After All
Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.
How this was made

The 30-second read
Why it matters
Regulatory scrutiny introduces legal risk, potential fines, and reputational damage, likely pressuring Cal-Maine's share price.
Market read
First report of a major antitrust probe into the egg industry, creating new risk for Cal-Maine and possibly the broader agribusiness sector.
What to watch
The impact of bird flu on supply may offset price-fixing concerns, sustaining demand-driven price support.
Background
The article details a DOJ investigation into alleged price-fixing by Cal-Maine, Hickman's Egg Ranch, and Versova, describing coordinated bidding on the Egg Clearinghouse.
Ticker impact
U.S. Justice Department alleges Cal-Maine coordinated price-fixing in the egg market, exposing the company to legal risk and potential fines.
likely pressure as market prices in regulatory risk.
Antitrust allegations can lead to fines, reputational damage, and increased scrutiny, which typically depresses share price.
Market effects
Potentially raises scrutiny on other large agribusinesses and could trigger broader sector risk for food producers.
May affect egg price dynamics in U.S. regional markets as suppliers adjust to legal exposure.
Limited to U.S. markets but could influence global commodity pricing perceptions.
Counterpoint
If the investigation stalls, Cal-Maine could emerge unscathed and benefit from reduced competition.
Key entities
- companyCal-Maine Foods
Largest publicly traded U.S. egg producer, ticker CALM.
- governmentU.S. Justice Department
Antitrust division leading the investigation.

